Malignant Tongue Neoplasm — Trials

Malignant Tongue Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

86 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 9%
Top sponsor: EvolveImmune United, Inc
Termination share: 31%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07346807	Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer	not yet recruiting	Phase 2	69	Shanghai Zhongshan HospitalOTHER	1	Jan 16, 2026	clinicaltrials

Data updated 23 days agoSource updated Jan 16, 2026source: clinicaltrials